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colleagues at the University of Southern California have presented
a 13-year experience of creating 101 arteriovenous ﬁstulas in 93
patients. The procedures were performed by only two surgeons.
The bulk of the procedures were radiocephalic ﬁstulas, but there
were a signiﬁcant number of brachiocephalic and basilic transposi-
tion ﬁstulas, and a small number of femoral transpositions. Eight-
two percent of the patients were already on hemodialysis at the
time of ﬁstula creation, and 78% had a prior central venous cath-
eter. Overall, their results are excellent and consistent with other
publications, with primary patency of 83% and secondary patency
of 92%. The authors found that gender, weight, etiology of renal
failure, previous central venous catheter and their location, and
whether the patient was already on dialysis had no impact on
patency. Only age inﬂuenced ﬁstula patency.
Strategies for management of renal failure are a little different
in the pediatric population, with preemptive transplant being the
ﬁrst preference and peritoneal dialysis also being more prevalent
than in adults. Nevertheless, >50% of pediatric patients requiring
renal replacement therapy end up on hemodialysis. Despite Kidney
Disease Outcomes Quality Initiative guidelines recommending
arteriovenous ﬁstula (AVF) as the preferred hemodialysis access
and literature showing short- and long-term success rates that
are even better than in adults, the majority of pediatric patients
receiving hemodialysis are dialyzing via central catheters. Review
of the manuscript does raise several questions:
The most important factor in dialysis access is usability, not ﬁs-
tula patency, yet you only report on the latter. Can you tell us how
many of these ﬁstulas were actually used and for how long?
Can you explain why you believe that age impacted ﬁstula
patency but not weight? It would seem that the two variables
should track each other to some extent.
There is no apparent analysis of outcomes depending on ﬁstula
type. I know the numbers are small, but did you evaluate whether
your outcomes were different for different types of ﬁstulas?
Can you tell us what proportion of your overall pediatric dial-
ysis population this report represents? What percentage of patientsat your institution are dialyzing via catheters and are on peritoneal
dialysis?
Finally, there was little information in the manuscript
regarding the decision-making process that was used for ﬁstula
type selection and technical details of you procedures that might
help others achieve these type of excellent results. Can you provide
us any information regarding those issues? I enjoyed the presenta-
tion and complement the authors on their results.
Dr Sarah M. Wartman. We would like to thank Dr Hye for
his thoughtful comments and questions. Indeed, pediatric end-
stage renal disease patients have certain considerations that are
different from the adult population. As Dr Hye has mentioned
in his discussion of our paper, there is a signiﬁcantly higher per-
centage of pediatric patients dialyzing through catheters than
adult hemodialysis patients. The question of why remains to be
answered and is outside the scope of this study. It is, nevertheless,
a source of concern when studying pediatric hemodialysis, and we
have an ongoing project that is designed evaluate the decision-
making process of pediatric hemodialysis patients and their par-
ents when choosing a catheter vs a ﬁstula. Because our current
paper speciﬁcally addresses outcomes with AVF placement, we
did not expand our data collection to include all hemodialysis
and peritoneal dialysis patients at our institution and, therefore,
did not capture the percentage of patients that dialyzed through
a catheter or with peritoneal dialysis.
In general, all ﬁstulas were performed with a standard end-to-
side anastomosis with a continuous running monoﬁlament suture,
with tourniquet occlusion in selected cases. Loupe magniﬁcation
was used for all cases and an operating microscope was used by
one of the two surgeons on a case-by-case basis. Femoral vein
transposition technique is described in Rutherford’s Vascular Sur-
gery and includes references to a technique described and reported
by Dr Wayne Gradman. All basilic and femoral vein transpositions
were performed in one stage. In our study, ﬁstula patency was not
affected by the location of the ﬁstula. Although the subset analysis
was limited by small numbers in some groups, it did not appear to
change the outcomes for patency.
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patency where a ﬁstula was considered patent only while being used
by the patient. For a large cohort of patients in this study, the end
of ﬁstula patency was their date of transplant, regardless of the fact
that their AVF could still be accessed and was still technically pat-
ent. In fact, there were some patients that actually went back to us-
ing their original AVF after transplant failure, but due to the
inability to follow all patients for this possible outcome, we didnot include this time period our analysis. With this in mind, our
patency data is an accurate reﬂectiondif not an underestimationd
of the usability of our patients’ arteriovenous ﬁstulas.
Finally, the reason for the signiﬁcant impact of age, but not
weight, on ﬁstula patency was perplexing to us. It is possible that
the size of vessel is not reﬂected as much by the patient’s weight
as it is by their age. In addition, only 5% of our patients weighed
<20 kg, which may have impacted our analysis.
